Company news

Inventiva SA news in 2026

Inventiva SA's news releases, calls and decks from 2026, newest first.

View company

Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026

October 6, 2026

Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités

September 27, 2026

Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update

September 28, 2026

Inventiva to Present Multiple Abstracts at Paris MASH 2026

September 8, 2026

Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026

September 7, 2026

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

September 2, 2026

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

September 1, 2026

Inventiva Appoints Chris Benecchi as Chief Operating Officer

August 31, 2026

Inventiva nomme Chris Benecchi au poste de Chief Operating Officer

August 30, 2026

Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹

July 30, 2026

Inventiva Announces Preliminary Financial Results for the First Half of 2026¹

July 29, 2026

Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants

July 9, 2026

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

July 2, 2026

Claret Capital Partners participates in €130m financing for Inventiva

June 16, 2026

Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development

June 16, 2026

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing

June 12, 2026

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents

June 9, 2026

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris

June 2, 2026

Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris

June 2, 2026

Inventiva Reports 2026 First Quarter Financial Information¹

May 26, 2026

Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor

April 22, 2026

Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F

April 8, 2026

Inventiva reports 2025 full year results and provides a business update

March 30, 2026

Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results

March 23, 2026

Inventiva to Participate in Four Upcoming March Investor Conferences

February 26, 2026

Inventiva reports preliminary 2025¹ fiscal year financial results

February 17, 2026

Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

February 4, 2026

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

January 26, 2026

Calls in 2026

Decks in 2026